N/A
Manufactured by Fresenius Kabi USA, LLC
50,066 FDA adverse event reports analyzed
Last updated: 2026-04-14
HALOPERIDOL LACTATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Fresenius Kabi USA, LLC. The most commonly reported adverse reactions for HALOPERIDOL LACTATE include DRUG INEFFECTIVE, DRUG INTERACTION, NEUROLEPTIC MALIGNANT SYNDROME, OFF LABEL USE, EXTRAPYRAMIDAL DISORDER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for HALOPERIDOL LACTATE.
Out of 23,959 classified reports for HALOPERIDOL LACTATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 50,066 FDA FAERS reports that mention HALOPERIDOL LACTATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, DRUG INTERACTION, NEUROLEPTIC MALIGNANT SYNDROME, OFF LABEL USE, EXTRAPYRAMIDAL DISORDER, WEIGHT INCREASED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Fresenius Kabi USA, LLC in connection with HALOPERIDOL LACTATE. Always verify the specific product and NDC with your pharmacist.